HT
AVIR icon

HAP Trading’s Atea Pharmaceuticals AVIR Stock Holding History

HAP Trading’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,700
Closed -$12K – 1730
2022
Q2 		$12K Sell
11,700
-24,300
-68% -$166K ﹤0.01% 1429
2022
Q1 		$9K Sell
36,000
-34,300
-49% -$233K ﹤0.01% 1796
2021
Q4 		$16K Buy
70,300
+55,200
+366% +$860K ﹤0.01% 1891
2021
Q3 		$109K Buy
15,100
+2,800
+23% +$77.7K ﹤0.01% 1230
2021
Q2 		$21K Buy
+12,300
New +$370K ﹤0.01% 1788

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return